Cargando…
Downregulating Notch counteracts Kras(G12D)-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm
The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-of-function NOTCH1 mutations are prevalent in human T cell leukemia, while loss of Notch si...
Autores principales: | Kong, Guangyao, You, Xiaona, Wen, Zhi, Chang, Yuan-I, Qian, Shuiming, Ranheim, Erik A., Letson, Christopher, Zhang, Xinmin, Zhou, Yun, Liu, Yangang, Rajagopalan, Adhithi, Zhang, Jingfang, Hofmann-Zhang, Inga, Zhong, Xuehua, Padron, Eric, Zhou, Lan, Pear, Warren S., Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405304/ https://www.ncbi.nlm.nih.gov/pubmed/30206308 http://dx.doi.org/10.1038/s41375-018-0248-0 |
Ejemplares similares
-
Nras(Q61R/+) and Kras(−/−) cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors
por: Wen, Zhi, et al.
Publicado: (2021) -
Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia
por: Chung, Wen-Cheng, et al.
Publicado: (2019) -
The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway
por: Aquila, Giorgio, et al.
Publicado: (2019) -
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
por: Jin, Heiying, et al.
Publicado: (2013) -
Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia
por: Baker, Stacey J., et al.
Publicado: (2019)